As of 1/31/2018 13:00, our instrument has been replaced and there should be no delay in testing.
Serum and Urine Osmolality requests will be delayed for up to 24 hours until further notice due to instrumentation malfunction. Please contact the Chemistry Department with any questions or concerns. We apologize for any inconvenience that this may cause.
As of 1/12/2018, the analyzer has been repaired and all specimens have been resulted.
The Dynex DS2 analyzer in the Chemistry department at Spectrum Health Regional Laboratory is currently down until Tuesday, January 2, 2018. Results for TB Screen (QuantiFERON Gold) on tests collected since December 21, 2017 will be delayed. Specimens are stable for 27 days, so the patient will not need to be recollected. We apologize for any inconvenience.
If you have further questions, please contact the Laboratory Call Center or use the “contact us” link above. This post will be updated when the analyzer is serviced.
Update 11/1/2017 – The analyzer is currently back up. Back-dated specimen processing will take up to 24 hours. Thank you for your patience during this time.
The BioPlex 2200 analyzer in the ImmunoChemistry department at Spectrum Health Regional Laboratory is currently down until Tuesday, October 31st, at the earliest. Results for HIV and Syphilis testing will be delayed. We apologize for any inconvenience.
If you have further questions, please contact the Laboratory Call Center or use the “contact us” link above.
Effective October 15th, 2017, all specimens collected for Blood Bank must have two signatures on the specimen written in ink that is resistant to smearing after a patient has been identified according to the Patient Identification Policy.
One of the two collectors/witnesses must be a lab staff member, unless specimen is collected in Spectrum Health Surgery, Infusion Center, Special Care Hospital, Cardiac Cath Lab Procedure Room, or a cord blood in Labor and Delivery. For Outpatients, the patient may serve as the witness and initial the tube label.
Laboratory Reporting Format Update—- effective June 3, 2017
The Spectrum Health Laboratory Information System is upgrading to a new format for printed/faxed reports on June 3, 2017.
On May 17, 2017, the US Food and Drug Administration (FDA) issued a safety communication warning against using venous samples on Point of Care Magellan Diagnostics LeadCare Testing System devices (LeadCare, LeadCare II, LeadCare Plus, and LeadCare Ultra). Venous specimens appear to be at risk for having falsely low results. Only Capillary (“finger stick” or “heel stick”) specimen types should be used.
IF YOUR OFFICE IS USING ANY OF THE MAGELLAN LEADCARE TESTING SYSTEM DEVICES: please DISCONTINUE the use of VENOUS specimens for testing.
Spectrum Health Regional Laboratory supplies purple priority bags for specimens that must be handled and processed immediately upon receipt in the laboratory. The purple color priority transport bag will be a visual cue to the receiving laboratory that the specimens inside the bag need to be handled or processed immediately at the time of arrival in the laboratory or the integrity of the specimen will be compromised.
Use these bags for transporting specimens to the laboratory when:
Leaky specimen containers may cause compromised test results and it is also a hazard to lab couriers and registration personnel. Please be sure to inform patients that leaky specimen containers are not acceptable and may be rejected.
In order to prevent leaky containers, please be sure to discuss the following tips:
In the College of American Pathologists publication CAP Today the question was asked, “Are there regulations guiding the practice of taking additional blood samples from a patient (in case additional testing is needed later) even though there are no orders for the blood samples?” The limited literature on this topic has shown that inpatients (in those studies) have had up to 700 mL of blood collected during hospital stays. Thus we have to step back and ask: Does that make sense?
Read the response offered by David N. Alter, MD, DABCC, Clinical/Chemical Pathologist, Spectrum Health Regional Laboratory.
Spectrum Health Laboratory strives to ensure that all marketing of laboratory services is honest, straightforward, fully informative and non-deceptive. The Spectrum Health’s Code of Conduct dictates that quality laboratory practices are followed and laboratory marketing activities must meet all government laws and regulations.